Loading…

From teratocarcinomas to embryonic stem cells

The recent derivation of human embryonic stem (ES) cell lines, together with results suggesting an unexpected degree of plasticity in later, seemingly more restricted, stem cells (so-called adult stem cells), have combined to focus attention on new opportunities for regenerative medicine, as well as...

Full description

Saved in:
Bibliographic Details
Published in:Philosophical transactions of the Royal Society of London. Series B. Biological sciences 2002-04, Vol.357 (1420), p.405-417
Main Author: Andrews, Peter W.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c760t-f9e4fd1383abc5003d80ab6722721b50a253c74964ee3728c1cebfae835d85633
cites cdi_FETCH-LOGICAL-c760t-f9e4fd1383abc5003d80ab6722721b50a253c74964ee3728c1cebfae835d85633
container_end_page 417
container_issue 1420
container_start_page 405
container_title Philosophical transactions of the Royal Society of London. Series B. Biological sciences
container_volume 357
creator Andrews, Peter W.
description The recent derivation of human embryonic stem (ES) cell lines, together with results suggesting an unexpected degree of plasticity in later, seemingly more restricted, stem cells (so-called adult stem cells), have combined to focus attention on new opportunities for regenerative medicine, as well as for understanding basic aspects of embryonic development and diseases such as cancer. Many of the ideas that are now discussed have a long history and much has been underpinned by the earlier studies of teratocarcinomas, and their embryonal carcinoma (EC) stem cells, which present a malignant surrogate for the normal stem cells of the early embryo. Nevertheless, although the potential of EC and ES cells to differentiate into a wide range of tissues is now well attested, little is understood of the key regulatory mechanisms that control their differentiation. Apart from the intrinsic biological interest in elucidating these mechanisms, a clear understanding of the molecular process involved will be essential if the clinical potential of these cells is to be realized. The recent observations of stem-cell plasticity suggest that perhaps our current concepts about the operation of cell regulatory pathways are inadequate, and that new approaches for analysing complex regulatory networks will be essential.
doi_str_mv 10.1098/rstb.2002.1058
format article
fullrecord <record><control><sourceid>jstor_royal</sourceid><recordid>TN_cdi_royalsociety_journals_10_1098_rstb_2002_1058</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>3066756</jstor_id><sourcerecordid>3066756</sourcerecordid><originalsourceid>FETCH-LOGICAL-c760t-f9e4fd1383abc5003d80ab6722721b50a253c74964ee3728c1cebfae835d85633</originalsourceid><addsrcrecordid>eNp9UV1vEzEQPCEQDYFXnhDKH7iwts9fLyBakYJUCYkWXlc-x9c45M6RfSmEX48vVwUiRJ9Wq53ZnZktipcE5gS0ehNTX88pAM0tV4-KCakkKamW8LiYgBa0VBUTZ8WzlNYAoLmsnhZnhAJVUrFJUS5iaGe9i6YP1kTru9CaNOvDzLV13IfO21nqXTuzbrNJz4snjdkk9-K-Touviw83Fx_Lq8-Xny7eX5VWCujLRruqWRKmmKktB2BLBaYWklJJSc3BUM6srLSonGOSKkusqxvjFONLxQVj0-LtuHe7q1u3tK7ro9ngNvrWxD0G4_F00vkV3oY7JEJTzXVeMB8X2BhSiq45cgngEBwOweEQHA7BZcLrvy_-gd8nlQFpBMSwz9aD9a7f4zrsYpdb_HJ9c060hjvGpScVBQTFCMiKMI2__PZwbwBgBqBPaefwADvV8a8s9tDV_5p5NbLWqQ_x6IWBEDLHO81fP4x9_uzP49jE7ygkkxy_qQpBKHG9ONd4mfEw4lf-dvXDR4cnanKzzecHXwdHFfBMefcgZdBrQ9fn950Qsdlt8p-XDfsNiOjgyw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>From teratocarcinomas to embryonic stem cells</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>PubMed Central</source><source>Royal Society Publishing Jisc Collections Royal Society Journals Read &amp; Publish Transitional Agreement 2025 (reading list)</source><creator>Andrews, Peter W.</creator><creatorcontrib>Andrews, Peter W.</creatorcontrib><description>The recent derivation of human embryonic stem (ES) cell lines, together with results suggesting an unexpected degree of plasticity in later, seemingly more restricted, stem cells (so-called adult stem cells), have combined to focus attention on new opportunities for regenerative medicine, as well as for understanding basic aspects of embryonic development and diseases such as cancer. Many of the ideas that are now discussed have a long history and much has been underpinned by the earlier studies of teratocarcinomas, and their embryonal carcinoma (EC) stem cells, which present a malignant surrogate for the normal stem cells of the early embryo. Nevertheless, although the potential of EC and ES cells to differentiate into a wide range of tissues is now well attested, little is understood of the key regulatory mechanisms that control their differentiation. Apart from the intrinsic biological interest in elucidating these mechanisms, a clear understanding of the molecular process involved will be essential if the clinical potential of these cells is to be realized. The recent observations of stem-cell plasticity suggest that perhaps our current concepts about the operation of cell regulatory pathways are inadequate, and that new approaches for analysing complex regulatory networks will be essential.</description><identifier>ISSN: 0962-8436</identifier><identifier>EISSN: 1471-2970</identifier><identifier>DOI: 10.1098/rstb.2002.1058</identifier><identifier>PMID: 12028783</identifier><language>eng</language><publisher>England: The Royal Society</publisher><subject>Animals ; Cell Differentiation ; Cell Line ; Cell lines ; Cell Transformation, Neoplastic ; Cellular differentiation ; Differentiation ; Embryo, Mammalian - cytology ; Embryonal Carcinoma ; Embryonic Stem Cells ; Embryos ; Germ cells ; Human ; Humans ; Neurons ; Plasticity ; Pluripotent stem cells ; Somatic cells ; Stem cells ; Stem Cells - cytology ; Stem Cells - metabolism ; Teratocarcinoma ; Teratocarcinoma - metabolism ; Teratocarcinoma - pathology</subject><ispartof>Philosophical transactions of the Royal Society of London. Series B. Biological sciences, 2002-04, Vol.357 (1420), p.405-417</ispartof><rights>Copyright 2001-2002 The Royal Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c760t-f9e4fd1383abc5003d80ab6722721b50a253c74964ee3728c1cebfae835d85633</citedby><cites>FETCH-LOGICAL-c760t-f9e4fd1383abc5003d80ab6722721b50a253c74964ee3728c1cebfae835d85633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/3066756$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/3066756$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793,58238,58471</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12028783$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Andrews, Peter W.</creatorcontrib><title>From teratocarcinomas to embryonic stem cells</title><title>Philosophical transactions of the Royal Society of London. Series B. Biological sciences</title><addtitle>Philos Trans R Soc Lond B Biol Sci</addtitle><description>The recent derivation of human embryonic stem (ES) cell lines, together with results suggesting an unexpected degree of plasticity in later, seemingly more restricted, stem cells (so-called adult stem cells), have combined to focus attention on new opportunities for regenerative medicine, as well as for understanding basic aspects of embryonic development and diseases such as cancer. Many of the ideas that are now discussed have a long history and much has been underpinned by the earlier studies of teratocarcinomas, and their embryonal carcinoma (EC) stem cells, which present a malignant surrogate for the normal stem cells of the early embryo. Nevertheless, although the potential of EC and ES cells to differentiate into a wide range of tissues is now well attested, little is understood of the key regulatory mechanisms that control their differentiation. Apart from the intrinsic biological interest in elucidating these mechanisms, a clear understanding of the molecular process involved will be essential if the clinical potential of these cells is to be realized. The recent observations of stem-cell plasticity suggest that perhaps our current concepts about the operation of cell regulatory pathways are inadequate, and that new approaches for analysing complex regulatory networks will be essential.</description><subject>Animals</subject><subject>Cell Differentiation</subject><subject>Cell Line</subject><subject>Cell lines</subject><subject>Cell Transformation, Neoplastic</subject><subject>Cellular differentiation</subject><subject>Differentiation</subject><subject>Embryo, Mammalian - cytology</subject><subject>Embryonal Carcinoma</subject><subject>Embryonic Stem Cells</subject><subject>Embryos</subject><subject>Germ cells</subject><subject>Human</subject><subject>Humans</subject><subject>Neurons</subject><subject>Plasticity</subject><subject>Pluripotent stem cells</subject><subject>Somatic cells</subject><subject>Stem cells</subject><subject>Stem Cells - cytology</subject><subject>Stem Cells - metabolism</subject><subject>Teratocarcinoma</subject><subject>Teratocarcinoma - metabolism</subject><subject>Teratocarcinoma - pathology</subject><issn>0962-8436</issn><issn>1471-2970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNp9UV1vEzEQPCEQDYFXnhDKH7iwts9fLyBakYJUCYkWXlc-x9c45M6RfSmEX48vVwUiRJ9Wq53ZnZktipcE5gS0ehNTX88pAM0tV4-KCakkKamW8LiYgBa0VBUTZ8WzlNYAoLmsnhZnhAJVUrFJUS5iaGe9i6YP1kTru9CaNOvDzLV13IfO21nqXTuzbrNJz4snjdkk9-K-Touviw83Fx_Lq8-Xny7eX5VWCujLRruqWRKmmKktB2BLBaYWklJJSc3BUM6srLSonGOSKkusqxvjFONLxQVj0-LtuHe7q1u3tK7ro9ngNvrWxD0G4_F00vkV3oY7JEJTzXVeMB8X2BhSiq45cgngEBwOweEQHA7BZcLrvy_-gd8nlQFpBMSwz9aD9a7f4zrsYpdb_HJ9c060hjvGpScVBQTFCMiKMI2__PZwbwBgBqBPaefwADvV8a8s9tDV_5p5NbLWqQ_x6IWBEDLHO81fP4x9_uzP49jE7ygkkxy_qQpBKHG9ONd4mfEw4lf-dvXDR4cnanKzzecHXwdHFfBMefcgZdBrQ9fn950Qsdlt8p-XDfsNiOjgyw</recordid><startdate>20020429</startdate><enddate>20020429</enddate><creator>Andrews, Peter W.</creator><general>The Royal Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20020429</creationdate><title>From teratocarcinomas to embryonic stem cells</title><author>Andrews, Peter W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c760t-f9e4fd1383abc5003d80ab6722721b50a253c74964ee3728c1cebfae835d85633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Cell Differentiation</topic><topic>Cell Line</topic><topic>Cell lines</topic><topic>Cell Transformation, Neoplastic</topic><topic>Cellular differentiation</topic><topic>Differentiation</topic><topic>Embryo, Mammalian - cytology</topic><topic>Embryonal Carcinoma</topic><topic>Embryonic Stem Cells</topic><topic>Embryos</topic><topic>Germ cells</topic><topic>Human</topic><topic>Humans</topic><topic>Neurons</topic><topic>Plasticity</topic><topic>Pluripotent stem cells</topic><topic>Somatic cells</topic><topic>Stem cells</topic><topic>Stem Cells - cytology</topic><topic>Stem Cells - metabolism</topic><topic>Teratocarcinoma</topic><topic>Teratocarcinoma - metabolism</topic><topic>Teratocarcinoma - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Andrews, Peter W.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Philosophical transactions of the Royal Society of London. Series B. Biological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Andrews, Peter W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>From teratocarcinomas to embryonic stem cells</atitle><jtitle>Philosophical transactions of the Royal Society of London. Series B. Biological sciences</jtitle><addtitle>Philos Trans R Soc Lond B Biol Sci</addtitle><date>2002-04-29</date><risdate>2002</risdate><volume>357</volume><issue>1420</issue><spage>405</spage><epage>417</epage><pages>405-417</pages><issn>0962-8436</issn><eissn>1471-2970</eissn><abstract>The recent derivation of human embryonic stem (ES) cell lines, together with results suggesting an unexpected degree of plasticity in later, seemingly more restricted, stem cells (so-called adult stem cells), have combined to focus attention on new opportunities for regenerative medicine, as well as for understanding basic aspects of embryonic development and diseases such as cancer. Many of the ideas that are now discussed have a long history and much has been underpinned by the earlier studies of teratocarcinomas, and their embryonal carcinoma (EC) stem cells, which present a malignant surrogate for the normal stem cells of the early embryo. Nevertheless, although the potential of EC and ES cells to differentiate into a wide range of tissues is now well attested, little is understood of the key regulatory mechanisms that control their differentiation. Apart from the intrinsic biological interest in elucidating these mechanisms, a clear understanding of the molecular process involved will be essential if the clinical potential of these cells is to be realized. The recent observations of stem-cell plasticity suggest that perhaps our current concepts about the operation of cell regulatory pathways are inadequate, and that new approaches for analysing complex regulatory networks will be essential.</abstract><cop>England</cop><pub>The Royal Society</pub><pmid>12028783</pmid><doi>10.1098/rstb.2002.1058</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0962-8436
ispartof Philosophical transactions of the Royal Society of London. Series B. Biological sciences, 2002-04, Vol.357 (1420), p.405-417
issn 0962-8436
1471-2970
language eng
recordid cdi_royalsociety_journals_10_1098_rstb_2002_1058
source JSTOR Archival Journals and Primary Sources Collection; PubMed Central; Royal Society Publishing Jisc Collections Royal Society Journals Read & Publish Transitional Agreement 2025 (reading list)
subjects Animals
Cell Differentiation
Cell Line
Cell lines
Cell Transformation, Neoplastic
Cellular differentiation
Differentiation
Embryo, Mammalian - cytology
Embryonal Carcinoma
Embryonic Stem Cells
Embryos
Germ cells
Human
Humans
Neurons
Plasticity
Pluripotent stem cells
Somatic cells
Stem cells
Stem Cells - cytology
Stem Cells - metabolism
Teratocarcinoma
Teratocarcinoma - metabolism
Teratocarcinoma - pathology
title From teratocarcinomas to embryonic stem cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T10%3A16%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_royal&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=From%20teratocarcinomas%20to%20embryonic%20stem%20cells&rft.jtitle=Philosophical%20transactions%20of%20the%20Royal%20Society%20of%20London.%20Series%20B.%20Biological%20sciences&rft.au=Andrews,%20Peter%20W.&rft.date=2002-04-29&rft.volume=357&rft.issue=1420&rft.spage=405&rft.epage=417&rft.pages=405-417&rft.issn=0962-8436&rft.eissn=1471-2970&rft_id=info:doi/10.1098/rstb.2002.1058&rft_dat=%3Cjstor_royal%3E3066756%3C/jstor_royal%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c760t-f9e4fd1383abc5003d80ab6722721b50a253c74964ee3728c1cebfae835d85633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/12028783&rft_jstor_id=3066756&rfr_iscdi=true